CBD is constantly gaining more popularity and presenting investment potential. Some people are unaware that there are over 100 compounds found in the cannabis plant, known as cannabinoids. A cannabinoid called CBG (Cannabigerol) has been garnering some recent attention and present opportunities to investors interested in putting money into businesses that sell CBG.
Full-spectrum cannabis medicine means that cannabinoids are derived from the whole plant. Cannabis experts tend to think that full-spectrum is best. CBG is known as the stem cell of all cannabinoids. It is non-psychoactive, but it works as the parent of all cannabinoids. This is why cannabis advocates and experts at companies like Colorado-based Steve’s Goods are excited about the possibility of CBG as medicine and could present itself as an investment opportunity as more much-needed research opens up.
“We have personally administered CBG to thousands of people at over 50 events. It's the most requested product on our website and we provide education to thousands of receptive people both in-person and online every month, said James Rowland, CEO of Steve’s Goods.